Ravulizumab, CAS 1803171-55-2

Product Description: Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Lee JW, et, al. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood. 2019 Feb 7;133(6):530-539.

CAS Number: 1803171-55-2

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Metabolic Disease

Solubility: H2O

Target: Complement System

• Artikelnummer: MEXHY-P99365-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99365-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK